The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Validation study of combination chemotherapy in vitro for biliary tract carcinoma.
 
Yasunari Sakamoto
No Relationships to Disclose
 
Hidenori Ojima
No Relationships to Disclose
 
Seri Yamagishi
No Relationships to Disclose
 
Chigusa Morizane
Honoraria - Lilly; Novartis; Pfizer; Yakult Honsha
Consulting or Advisory Role - AstraZeneca; Novartis; Yakult Honsha
Research Funding - GlaxoSmithKline (Inst); Nobelpharma (Inst); Pfizer (Inst)
 
Hiroko Hosoi
No Relationships to Disclose
 
Shunsuke Kondo
No Relationships to Disclose
 
Hideki Ueno
Honoraria - Taiho Pharmaceutical
Research Funding - Lilly (Inst)
 
Takuji Okusaka
Honoraria - Bayer; Chugai Pharma; Dainippon Sumitomo Pharma; Eisai; Lilly; Merck Serono; Novartis; Pfizer; Taiho Pharmaceutical
Consulting or Advisory Role - Amgen (Inst); Chugai Pharma (Inst); Dainippon Sumitomo Pharma (Inst); Lilly (Inst); NanoCarrier (Inst); Nippon Boehringer Ingelheim (Inst); Nobelpharma (Inst); Novartis (Inst); OncoTherapy Science (Inst); Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Yakult Honsha (Inst); Zeria Pharmaceutical (Inst)
Research Funding - AstraZeneca (Inst); Bayer (Inst); Chugai Pharma (Inst); Dainippon Sumitomo Pharma (Inst); Eisai (Inst); Kowa (Inst); Kyowa Hakko Kirin (Inst); Lilly (Inst); Merck Serono (Inst); Nippon Boehringer Ingelheim (Inst); Novartis (Inst); OncoTherapy Science (Inst); Ono Pharmaceutical (Inst); Otsuka (Inst); Pfizer (Inst); Sceti Medical Labo (Inst); Shizuoka (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Yakult Honsha (Inst)
 
Yae Kanai
No Relationships to Disclose